DK0570414T3 - Naphthoquinonderivater til behandling af kronisk inflammation - Google Patents

Naphthoquinonderivater til behandling af kronisk inflammation

Info

Publication number
DK0570414T3
DK0570414T3 DK92903652T DK92903652T DK0570414T3 DK 0570414 T3 DK0570414 T3 DK 0570414T3 DK 92903652 T DK92903652 T DK 92903652T DK 92903652 T DK92903652 T DK 92903652T DK 0570414 T3 DK0570414 T3 DK 0570414T3
Authority
DK
Denmark
Prior art keywords
pct
menadione
treatment
chronic inflammation
naphthoquinone derivatives
Prior art date
Application number
DK92903652T
Other languages
English (en)
Inventor
Joseph Chayen
Lucille Bitensky
George Thomas Baxter Frost
Original Assignee
Ks Biomedix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919102340A external-priority patent/GB9102340D0/en
Priority claimed from GB919124541A external-priority patent/GB9124541D0/en
Application filed by Ks Biomedix Ltd filed Critical Ks Biomedix Ltd
Application granted granted Critical
Publication of DK0570414T3 publication Critical patent/DK0570414T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK92903652T 1991-02-04 1992-02-03 Naphthoquinonderivater til behandling af kronisk inflammation DK0570414T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919102340A GB9102340D0 (en) 1991-02-04 1991-02-04 Therapeutic compounds
GB919124541A GB9124541D0 (en) 1991-11-19 1991-11-19 Therapeutic compounds
PCT/GB1992/000196 WO1992013532A2 (en) 1991-02-04 1992-02-03 Naphthoquinone derivatives for the treatment of chronic inflammation

Publications (1)

Publication Number Publication Date
DK0570414T3 true DK0570414T3 (da) 2000-11-06

Family

ID=26298390

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92903652T DK0570414T3 (da) 1991-02-04 1992-02-03 Naphthoquinonderivater til behandling af kronisk inflammation

Country Status (10)

Country Link
US (1) US5763479A (da)
EP (1) EP0570414B1 (da)
JP (1) JP3251582B2 (da)
AT (1) ATE194283T1 (da)
AU (1) AU1195092A (da)
DE (1) DE69231222T2 (da)
DK (1) DK0570414T3 (da)
ES (1) ES2149168T3 (da)
GR (1) GR3034445T3 (da)
WO (1) WO1992013532A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2149633C1 (ru) * 1999-09-01 2000-05-27 Хачатрян Ашот Папикович Способ лечения иммунодефицитных состояний организма
WO2001064214A2 (en) * 2000-02-28 2001-09-07 The University Of British Columbia Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
GB0104571D0 (en) * 2001-02-23 2001-04-11 Ks Biomedix Holdings Plc Composition
GB0117326D0 (en) * 2001-07-16 2001-09-05 Univ Aberdeen Napthoquinone-type inhibitors of protein aggregation
EP1558922B1 (en) * 2002-10-30 2013-02-27 Ampere Life Sciences, Inc. Identifying therapeutic compounds based on their physical-chemical properties
ITMI20031011A1 (it) * 2003-05-20 2004-11-21 Vanetta S P A Composti biocidi per il trattamento delle acque.
US20070009450A1 (en) * 2004-09-03 2007-01-11 Susanne Emig Preparation, in particular cosmetic preparation, process for the...
KR100769708B1 (ko) 2006-09-21 2007-10-23 한국생명공학연구원 살충활성을 갖는 설포닐 나프토퀴논류 화합물들의유기합성방법과 살충제 이용 기술

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2367302A (en) * 1940-03-25 1945-01-16 Abbott Lab Bisulphite derivatives of 2-methyl-1, 4-naphthoquinone and the like
DE3347658A1 (de) * 1983-12-31 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln 1.4-naphthochinonderivate mit entzuendungshemmender wirkung

Also Published As

Publication number Publication date
WO1992013532A2 (en) 1992-08-20
DE69231222D1 (de) 2000-08-10
GR3034445T3 (en) 2000-12-29
ES2149168T3 (es) 2000-11-01
DE69231222T2 (de) 2001-03-01
WO1992013532A3 (en) 1992-10-29
JPH06505005A (ja) 1994-06-09
AU1195092A (en) 1992-09-07
ATE194283T1 (de) 2000-07-15
EP0570414A1 (en) 1993-11-24
JP3251582B2 (ja) 2002-01-28
US5763479A (en) 1998-06-09
EP0570414B1 (en) 2000-07-05

Similar Documents

Publication Publication Date Title
ES2091467T3 (es) Composicion y metodo para mejorar el bronceado solar.
ES2117646T3 (es) Alteracion de la velocidad y el caracter del crecimiento del pelo.
DE68928874D1 (de) Biozide Zusammensetzungen
ATE192649T1 (de) Stereochemische wortmanninderivate
DE69827777D1 (de) Zusammensetzungen mit verzögerter Wirkstoffabgabe zur Behandlung der Hyperlipidämie
IS4923A (is) Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara
ES2156120T3 (es) Derivados arilamidicos.
DK0888327T3 (da) Benzopyranderivater, som har antagonistisk virkning imod leukotriener
DK0570414T3 (da) Naphthoquinonderivater til behandling af kronisk inflammation
MX9202132A (es) Imidazobenzoquinonas y composicion que las contienen para prevenir o tratar la hipertension o el fallo cardiaco congestivo.
ES2187738T3 (es) Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.
ATE30583T1 (de) Vitamin-d3-derivate.
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.
ES2066546T3 (es) Composicion farmaceutica para inhibir la resorcion osea.
IT1247796B (it) Derivati arilvinilamidici e procedimento per la loro preparazione
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
FI880960A (fi) Anvaendning av rnas l inhibitor som markeringsaemne i virusinfektioner.
NO20001758L (no) FremgangsmÕter og blandinger for behandling av leddgikt
ATE147628T1 (de) Iloprost mit wirkung gegen cerebrale malaria
ES2158887T3 (es) Procedimiento para tratar la prostatitis cronica con 17 beta-n-terc-butilcarbamoil-4-aza-5 alfa-androst-1-en-ona.
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
DE69108357D1 (de) Behandlung von verdünnten säurehaltigen Lösungen.
ES2084657T3 (es) Agente para el tratamiento de los trastornos del sistema de transmision cerebro-neural.
ES2119814T3 (es) Metodo para la separacion de mezclas de gibberelinas.